The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare ...

It's the second year in a row that Medicare will negotiate drug prices after the Inflation Reduction Act authorized it to do ...

Ozempic was one of the 15 drugs selected for the 2027 Medicare drug price negotiation program three days before ...

A 2022 study found that after stopping the medication, participants regained two-thirds of the weight they had lost within 1 year. Learn more about Ozempic, including dosing, side effects ...

The negotiated prices of 15 Medicare Part D drugs, which include several blockbusters, will go into effect in 2027.

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

The high cost of GLP-1 drugs is also putting a strain on Medicare, which spent $4.6 billion on Ozempic for enrollees with diabetes in 2022, prior to discounts and rebates, according to KFF.

According to CMS data, Medicare Part D spending on Ozempic was more than $4.6 billion in 2022. Semaglutide’s selection was based on a set of criteria in the Inflation Reduction Act (IRA).

However, unlike Mounjaro and Ozempic, Zepbound is FDA approved for weight loss in adults when combined with diet and lifestyle changes. While research is ongoing, a landmark 2022 study of more ...

It's the second year in a row that Medicare will negotiate drug prices after the Inflation Reduction Act authorized it to do so in 2022. Blockbuster weight loss drug Ozempic could get cheaper by ...